BR112017018442A2 - composições injetáveis de ação prolongada compreendendo um agente ativo de isoxazolina, métodos e usos das mesmas - Google Patents

composições injetáveis de ação prolongada compreendendo um agente ativo de isoxazolina, métodos e usos das mesmas

Info

Publication number
BR112017018442A2
BR112017018442A2 BR112017018442A BR112017018442A BR112017018442A2 BR 112017018442 A2 BR112017018442 A2 BR 112017018442A2 BR 112017018442 A BR112017018442 A BR 112017018442A BR 112017018442 A BR112017018442 A BR 112017018442A BR 112017018442 A2 BR112017018442 A2 BR 112017018442A2
Authority
BR
Brazil
Prior art keywords
active agent
acting injectable
methods
long acting
isoxazoline active
Prior art date
Application number
BR112017018442A
Other languages
English (en)
Other versions
BR112017018442B1 (pt
Inventor
Galeska Izabela
Le Hir De Fallois Loic
Cheifetz Peter
Mancini Cady Susan
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of BR112017018442A2 publication Critical patent/BR112017018442A2/pt
Publication of BR112017018442B1 publication Critical patent/BR112017018442B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/04—Insecticides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

esta invenção se refere a formulações injetáveis de ação prolongada para combater parasitas em animais, compreendendo pelo menos um agente ativo isoxazolina, um poloxâmero e um co-solvente. esta invenção também proporciona métodos melhorados para erradicar, controlar e prevenir infecções e infestações de parasitas em um animal compreendendo administrar as formulações injetáveis de ação prolongada da invenção ao animal que dela necessite.
BR112017018442-7A 2015-02-26 2016-02-26 Composições injetáveis de ação prolongada compreendendo um agente ativo de isoxazolina, métodos e usos das mesmas BR112017018442B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562121350P 2015-02-26 2015-02-26
US62/121,350 2015-02-26
PCT/US2016/019688 WO2016138339A1 (en) 2015-02-26 2016-02-26 Long-acting injectable formulations comprising an isoxazoline active agent, methods and uses thereof

Publications (2)

Publication Number Publication Date
BR112017018442A2 true BR112017018442A2 (pt) 2018-04-17
BR112017018442B1 BR112017018442B1 (pt) 2023-08-29

Family

ID=

Also Published As

Publication number Publication date
AR103803A1 (es) 2017-06-07
AU2016222532B2 (en) 2018-07-12
MX2017010740A (es) 2017-12-04
CL2017002164A1 (es) 2018-04-27
US10561641B2 (en) 2020-02-18
NZ734948A (en) 2018-07-27
US20160256442A1 (en) 2016-09-08
EA201791910A1 (ru) 2017-12-29
EA035993B1 (ru) 2020-09-10
JP2018509405A (ja) 2018-04-05
KR20170131464A (ko) 2017-11-29
JP6789232B2 (ja) 2020-11-25
CN107427496B (zh) 2021-05-14
CA2977376A1 (en) 2016-09-01
KR102560198B1 (ko) 2023-07-26
AU2016222532A1 (en) 2017-09-21
EP3261617A1 (en) 2018-01-03
US20200022959A1 (en) 2020-01-23
AU2018205137B2 (en) 2019-08-08
CN107427496A (zh) 2017-12-01
JP7089564B2 (ja) 2022-06-22
AU2018205137A1 (en) 2018-08-02
EA201992772A1 (ru) 2020-06-26
MX2020009010A (es) 2020-10-12
UY36570A (es) 2016-10-31
JP2021008485A (ja) 2021-01-28
CO2017008584A2 (es) 2017-11-10
US11484528B2 (en) 2022-11-01
WO2016138339A1 (en) 2016-09-01
AU2019261769A1 (en) 2019-12-05
CA2977376C (en) 2024-03-05

Similar Documents

Publication Publication Date Title
BR112017021073A2 (pt) composições injetáveis de liberação prolongada compreendendo um agente ativo de isoxazolina, seus métodos e usos
BR112018017265A2 (pt) compostos antiparasíticos de isoxazolina, formulações injetáveis de ação prolongada que os compreendem, métodos e utilizações dos mesmos
CO2017008584A2 (es) Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
BR112014019262A8 (pt) Composições orais veterinárias parasíticas compreendendo ingredientes ativos de ação sistêmica, métodos e uso das mesmas
CR20180572A (es) COMPOSICIONES PARASITICIDAS QUE COMPRENDEN UN AGENTE ACTIVO DE ISOXAZOLINA, SUS METODOS Y USOS (Divisional 2014-0117)
CO2018006527A2 (es) Compuestos depsipeptídicos como anthelmínticos
BR112012025203A2 (pt) composições parasiticidas compreendendo múltiplos agentes ativos, método e usos das mesmas
UY36460A (es) Pirazolpiridinaminas
BR112016029888A2 (pt) composições parasiticidas compreendendo derivados de indol, métodos e usos dos mesmos
CO2019008053A2 (es) Agente terapéutico para enfermedades del hígado
CR20150508A (es) Formulaciones veterinarias estables de combinación de lactonas macrocíclicas e imidazotiazoles
AR126245A2 (es) Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25G Requested change of headquarter approved

Owner name: MERIAL, INC. (US)

B25A Requested transfer of rights approved

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. (US)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/02/2016, OBSERVADAS AS CONDICOES LEGAIS